We advocate for streamlined FDA and DEA coordination, including concurrent DEA 8-Factor Analysis during the FDA review process, to accelerate approvals and prevent unnecessary delays in patient access.
Securing necessary appropriations to ensure the VA healthcare system is fully prepared for the introduction and implementation of these therapies at launch, ensuring veterans have timely access to care.
Information on the House PATH Caucus and the pilot Senate PATH Caucus launching in 2026.
The Association for Prescription Psychedelics is the primary scientific and policy resource for the future of FDA-approved medicine. Join us in advocating for the development and accessibility of life-changing treatments.